throbber
NOTE
`
`Silicone Oil Induced Aggregation of Proteins
`
`LATOYA S. JONES, ALLYN KAUFMANN, C. RUSSELL MIDDAUGH
`
`Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047 3729
`
`Received 16 September 2004; revised 7 December 2004; accepted 10 January 2005
`
`Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jps.20321
`
`ABSTRACT: Prior to delivery to the patient, protein pharmaceuticals often come in
`contact with a variety of surfaces (e.g., syringes and stoppers), which are treated to
`facilitate processing or to inhibit protein binding. One such coating, silicone oil, has
`previously been implicated in the induction of protein aggregation. We have investigated
`the propensity of model proteins to aggregate when silicone oil is present in solution and
`find significant induction of aggregation in four proteins of various molecular weights
`and isoelectric points in the presence of 0.5% oil. The ability of silicone oil to induce
`conformational changes that might be responsible for this aggregation was also examined
`by a combination of circular dichroism (CD) and derivative UV spectroscopy. Neither
`method produces evidence of large conformational changes or alterations in thermal
`stability although in a limited number of cases some small changes suggest the possibility
`of minor structural alterations. The most probable explanation for silicone oil induced
`aggregation is that the oil has direct effects on intermolecular interactions responsible for
`protein association through interaction with protein surfaces or indirectly through
`effects on the solvent. ß 2005 Wiley Liss, Inc. and the American Pharmacists Association J
`Pharm Sci 94:918 927, 2005
`Keywords: protein aggregation; UV-vis spectroscopy; silicone oil; circular dichroism
`
`Silicone oil contamination has long been sus-
`pected of being responsible in some cases for the
`aggregation seen in certain protein pharmaceuti-
`cal preparations. Several publications in the 1980s
`implicated the release of silicone oil from dis-
`posable plastic syringes in the aggregation of
`insulin.1 – 5 The link between insulin aggregation
`and silicone oil was originally based on the
`observation that after multiple withdrawals from
`vials, patients using multi-dose preparations of
`insulin observed clouding of the solutions. In this
`regard, Chantelau et al. report a silicone oil
`contamination of up to 0.25 mg/mL in a 10 mL
`
`Correspondence to: C. Russell Middaugh (Telephone: 785
`864 5813; Fax: 785 864 5875; E mail: middaugh@ku.edu)
`
`Journal of Pharmaceutical Sciences, Vol. 94, 918–927 (2005)
`ß 2005 Wiley-Liss, Inc. and the American Pharmacists Association
`
`insulin vial when a standard procedure for filling
`1 mL siliconized syringes was performed three
`times each using 10 syringes.2 Referencing sili-
`cone oil contamination levels reported by a syringe
`manufacturer,6 Bernstein calculated that some
`of his patients who were prescribed low doses
`of insulin could have vials containing 4 mg of
`silicone oil when only 1/3 of the vial had been used.4
`The use of silicone oil is not limited to syringes. It is
`also used as a coating for porous glass vials to
`minimize protein adsorption and as a lubricant
`to prevent the conglomeration of rubber stoppers
`during filling procedures. In addition, it is the
`author’s experience that questions of silicone oil
`contamination and its potential role in protein
`aggregation arise frequently during the phar-
`maceutical development of proteins generally,
`although little information about this potential
`
`918
`
`JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 94, NO. 4, APRIL 2005
`
`Novartis Exhibit 2253.001
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`problem is available in the scientific literature.
`Thus, the possibility that silicone oil
`induces
`the aggregation of proteins could have important
`implications for a wide variety of protein formula-
`tion and process development related phenomena.
`Therefore, the purpose of this investigation
`was to assess the ability of silicone oil to induce
`aggregation of a variety of proteins over a range of
`pH and to investigate whether several biophysical
`techniques that are sensitive to changes in protein
`secondary and tertiary structure can detect sili-
`cone oil
`induced conformational changes that
`might be responsible for aggregation. Four model
`proteins (ribonuclease A (RNase A), lysozyme,
`bovine serum albumin (BSA), and concanavalin A
`(ConA)) with a wide range of different physical
`characteristics were used (Table 1). The choice
`of buffer pH was based on both pharmaceu-
`tical relevance and the well-characterized pH-
`dependent oligomerization state of ConA.7 At the
`lowest pH examined (4.5), ConA is a dimer. At
`pH 6.5, it exists in dimeric and tetrameric forms.
`Above pH 7.0, ConA is primarily a tetramer.
`
`EXPERIMENTAL
`
`Materials
`
`Chicken egg white lysozyme (L7651), bovine
`serum albumin (A3294), ConA from Canavalia
`ensiformis (C7275), and ribonuclease A from
`bovine pancreas (R5125) were purchased from
`Sigma Chemical Company (St. Louis, MO). These
`proteins can be lyophilized without a high content
`lyoprotectant. Thus, all proteins were supplied
`as essentially salt-free lyophilized powders and
`were used without further purification. Silicone
`oil (S159–500) was purchased from Fisher Chemi-
`cal Company (Pittsburgh, PA). All buffer salts
`(sodium phosphate monobasic, sodium phosphate
`
`Table 1. Model Proteins
`
`SILICONE OIL INDUCED PROTEIN AGGREGATION
`
`919
`
`dibasic, sodium acetate, and sodium chloride)
`were ACS grade or higher. Solutions were pre-
`pared using distilled deionized water.
`
`Methods
`
`Preparation of Stock Solutions
`
`Three buffers (10 mM sodium phosphate, 130 mM
`NaCl, pH 6.5 and pH 7.2 and 10 mM sodium
`acetate, 130 mM NaCl, pH 4.5) were used. A stock
`solution (suspension) of 1% (w/v) silicone oil in
`buffer was prepared by combining silicone oil and
`buffer in a 50 mL polypropylene centrifuge tube
`and sonicating for 10 min in an FS30 (Fisher
`Scientific) ultrasonicating bath to create a disper-
`sion. All silicone oil suspensions were freshly pre-
`pared on the day they were used. Over the period
`of the experiments, the resulting dispersions were
`stable as judged by constant optical properties.
`Protein solutions were prepared in each buffer
`by adding buffer to an appropriate amount of lyo-
`philized protein to obtain a protein concentration
`between 1 and 2 mg/mL. The concentration of the
`protein was then determined based on its extinc-
`tion coefficient, and additional buffer was added
`to adjust the protein concentration to 1 mg/mL.
`The proteins were kept on ice or refrigerated until
`used.
`
`Turbidity
`
`Optical density measurements were used to
`monitor protein aggregation. Equal volumes of
`protein and silicone oil stock solutions were
`combined in 1.7 mL microcentrifuge tubes to
`create concentrations of protein and silicone oil
`of 0.5 mg/mL and 0.5% (w/v), respectively. The
`samples were mixed by gentle pipetting and in-
`spected visually to ensure a homogeneous appear-
`ance. Control protein samples in each buffer were
`
`No. of Various Types of Secondary Structure Units
`
`Protein
`
`Molecular Weight and (pI)12
`
`Helices
`
`b-Sheets
`
`Turns
`
`Ribonuclease A (RNase A)
`Lysozyme
`Bovine serum albumin (BSA)
`Concanavalin A (ConA)b
`
`13.7 kDa (8.8)
`14.4 kDa (11.0)
`66 kDa (4.9)
`102 kDa (tetramer) (4.5 5.5)
`
`4
`4
`60
`5
`
`12
`5
`
`26
`
`13
`11
`
`aSecondary structure content are based on the following structures deposited in the Protein Databank (RNase A: 4RAT; lysozyme:
`4LYZ; BSA: 1AO6; ConA: 1APN). http://www.rcsb.org/pdb/
`bThe secondary structure content of ConA is given for a monomer unit.
`
`JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 94, NO. 4, APRIL 2005
`
`Novartis Exhibit 2253.002
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`920
`
`JONES, KAUFMANN, AND MIDDAUGH
`
`prepared similarly by substituting the appro-
`priate buffer for the 1% silicone oil suspension.
`Silicone oil buffer blanks were prepared by
`combining equal volumes of silicone oil (1%) with
`the appropriate buffer. The protein samples and
`their corresponding buffer blanks (all in quad-
`ruplet) were then transferred to an untreated
`96-well microtiter plate. This plate was placed in a
`FLUOstar Galaxy (BMG Labtechnologies, Dur-
`ham, NC) microtiter plate reader that had been
`preheated to 458C. The instrument was pro-
`grammed to record the OD360 of the wells every
`5 min for 5 h. Immediately before the beginning
`of a cycle (one round of reading all of the wells in
`the plate), the plate was gently shaken using a
`4 mm orbital displacement for 5 s. The data was
`transferred to an Excel spreadsheet for analysis.
`The values recorded for all wells containing pro-
`tein were corrected for extraneous scattering by
`subtracting the average of the wells containing
`the corresponding buffer, with or without silicone
`oil. Changes in optical density were calculated by
`subtracting the buffer corrected OD360 of the
`silicone oil-free sample from the sample contain-
`ing 0.5% silicone oil.
`
`Secondary Structure Changes and
`Tm Determinations
`
`Circular dichroism (CD) spectroscopy was used to
`determine the effect of 0.5% silicone oil on the
`secondary structure and Tm of the model proteins.
`The samples and buffer blanks were prepared as
`described above, except a protein concentration of
`0.2 mg/mL was employed. A 0.1 cm pathlength
`cell was used for data collection. Far UV CD
`spectra of the samples and buffer at 208C were
`recorded using a Jasco J-720 CD spectropolari-
`meter (Easton, MD). The spectra of appropriate
`buffers were subtracted from the spectra of the
`protein samples prior to comparison. The Tm of
`each protein sample was determined by recording
`the signal at 222 nm as the temperature was
`increased from 20 to 908C at a rate of 158C per
`hour and analyzing the resulting trace using the
`Jasco thermal denaturation analysis algorithm.
`
`Second Derivative UV Spectroscopy
`
`The effect of silicone oil (0.5%) on the tertiary
`structure of the model proteins as a function of
`temperature was investigated using 2nd deriva-
`tive analysis of UV spectra. The samples were
`prepared as described for the OD360 studies. The
`absorbance spectra were collected from 20 to 908C
`
`JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 94, NO. 4, APRIL 2005
`
`in 2.58C intervals using an Agilent 8453 UV-
`Visible spectrophotometer (Palo Alto, CA). The
`temperature of the cell holder was controlled
`using a Peltier device and the sample was equi-
`librated at each temperature for 5 min prior to
`data collection. Data were collected at 1 nm in-
`tervals with a 25 s averaging time. Spectral anal-
`ysis was performed using a splining procedure as
`previously described using ChemStation software
`(Agilent).8
`
`RESULTS AND DISCUSSION
`
`Protein Aggregation
`
`The solution parameters for the aggregation
`study were selected to permit detection of protein
`aggregates due to the presence of silicone oil over
`a relatively short time. This primarily involved
`selection of an appropriate experimental tem-
`perature and silicone oil concentration. Thus, we
`selected conditions for all proteins such that only
`small changes in optical density occurred when
`silicone oil was not present. Although we have
`attributed the increases in turbidity to protein
`aggregation,
`it is possible that the observed
`increases are caused, at least in part, by the effect
`of the protein on the silicone oil dispersion itself.
`Unfortunately, there is no obvious experimental
`method to easily distinguish between this and
`turbidity increases due to protein aggregation.
`Our assumption that protein association is res-
`ponsible for turbidity is based on the fact that
`aggregated protein can be separated by centrifu-
`gation from the protein/silicone oil emulsions and
`directly identified in the pelleted material. It is
`also important to note that by monitoring the
`OD360 of the solutions as a convenient method
`for rapidly detecting protein aggregation, soluble
`aggregates may not be detected due to their simi-
`lar size and reduced refractive indices.
`At 458C, protein aggregation was minimal to
`undetectable at all three pH values in the absence
`of silicone oil (Figure 1). By including 0.25% or
`less silicone oil in the protein samples, there was
`little to no increase in the protein optical density
`under these same conditions (data not shown)
`at short times, indicating that insoluble aggre-
`gates were not formed (although the formation of
`soluble aggregates is not precluded). At a silicone
`oil concentration of 0.5% and over a period of 5 h,
`however, the protein solutions exhibited chan-
`ges in optical density indicative of aggregation
`
`Novartis Exhibit 2253.003
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`A
`
`ConA
`
`0
`
`E 0.2
`=
`""

`
`<l
`
`SILICONE OIL INDUCED PROTEIN AGGREGATION
`
`921
`
`B
`0.4
`
`0
`SJ
`"'
`.2 3
`
`0
`
`E
`=
`0
`""
`6
`0
`<l
`
`0.2
`
`BSA
`
`0
`~ ' b o
`
`.4
`
`0
`~
`.2 3
`
`0
`
`0.0
`
`0
`
`60
`
`180
`120
`time (minutes)
`
`240
`
`.0
`300
`
`RNaseA
`
`C
`
`0.2
`
`0.0
`
`E
`=
`0
`""

`
`<l
`
`0.4
`
`~ ~ 0.2
`""
`0 §
`=
`0.2 3
`
`0
`
`<l
`
`0.0
`
`0.0
`0
`
`D
`
`60
`
`180
`120
`time (minutes)
`
`240
`
`.0
`300
`
`lysozyme
`
`0.4
`
`0
`~
`=
`3
`
`0
`
`0
`
`60
`
`180
`120
`time (minutes)
`
`240
`
`0.0
`300
`
`0
`
`60
`
`180
`120
`time (minutes)
`
`240
`
`0.0
`300
`
`Figure 1. Effect of silicone oil (0.5%) on the optical density of model proteins at 458C.
`(A) Con A, (B) BSA, (C) RNase A, (D) lysozyme. The left y-axes refer to the white symbols
`and the right to the black. DOD360 is the optical density of the protein sample containing
`the silicone oil minus the optical density of the corresponding protein sample lacking
`silicone oil. White squares: DOD360 at pH 4.5; white triangles: DOD360 at pH 6.5; white
`circle: DOD360 at pH 7.2. The black symbols represent protein samples lacking silicone oil
`(control samples). Black squares: OD360 at pH 4.5; black triangles: OD360 at pH 6.5; black
`circles: OD360 at pH 7.2. The error bars represent the SEM of four replicates.
`
`(Figure 1). The extent and rate of the optical
`density changes are both protein and pH depen-
`dent. Although the 0.5% concentration of the oil
`employed is somewhat higher than that normally
`detected in protein pharmaceutical preparations,
`the amount employed can be considered as only
`a moderately accelerated condition, an approach
`usually deemed acceptable to replicate the longer
`times and lower silicone oil concentrations of more
`immediate interest.
`Silicone oil (0.5%) caused the OD360 of ConA at
`pH 4.5 to increase 0.19 U over the course of the first
`200 min (Figure 1A). The turbidity remained at
`this level for another hour, after which there was a
`slight decrease. At pH 6.5, the initial ConA
`aggregation occurred more rapidly and induced a
`greater change in OD360 (DOD 0.24 U in 100 min).
`At 200 min, the OD360 began a slight decline.
`Silicone oil had the least effect on ConA at pH 7.2,
`
`inducing an increase in OD360 of only 0.08 U within
`the first 50 min with the characteristic decline
`appearing at 240 min. ConA has previously
`been described as a hydrophobic protein due to
`its adsorption to hydrophobic surfaces. The de-
`crease in the effects of silicone oil on ConA at pH 7.2
`in comparison to the other pH values may be
`related to the fact that ConA is a tetramer at
`pH 7.2, potentially reducing exposure of a sub-
`unit interface that could interact with the oil.9,10
`The decline in OD360 after an initial increase
`observed for ConA at all pH values could reflect
`settling of aggregated material or the creation of
`particles with a reduced refractive index incre-
`ment (see below).
`The most dramatic silicone oil induced aggrega-
`tion occurred with BSA, as seen by the significant
`increase in optical density within the first 5 min at
`all pH values investigated (Figure 1B). The initial
`
`JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 94, NO. 4, APRIL 2005
`
`Novartis Exhibit 2253.004
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`922
`
`JONES, KAUFMANN, AND MIDDAUGH
`
`change in OD360 for BSA at each pH was essen-
`tially identical (DOD360 0.13 U after 5 min). The
`change over the course of the experiment was
`pH dependent. At pH 4.5, the optical density of
`the BSA/silicone oil suspension increased slightly
`during the remainder of the incubation (<0.04 U
`increase in OD360 within the first 60 min). The
`largest increase in the turbidity of BSA was
`observed at pH 7.2, with a steep increase during
`the first 60 min followed by a slower rise for the
`duration of the incubation. The turbidity of the
`BSA/silicone oil solution at pH 6.5 increased
`steadily, albeit at a slower rate than the increase
`observed for the pH 7.2 system, following the
`initial jump at 5 min. At the end of 5 h, the OD of
`the pH 6.5 BSA/silicone oil solution was nearly
`equivalent to that at pH 7.2.
`Silicone oil induced aggregation of RNase A was
`greatest at pH 4.5 (Figure 1C). At this pH, the
`OD360 of the RNase A/silicone oil dispersion
`increased 0.2 U during the first 120 min. The
`pH 6.5 RNase A/silicone oil dispersion displayed a
`similar trend, but had a much smaller increase
`in the OD360. At pH 7.2, RNase A aggregation
`resulted in a decline in the OD360 during the first
`30 min followed by an increase that only begins
`to level off during the last 15 min of the 5 h
`incubation.
`The effect of silicone oil on the optical density of
`lysozyme differed dramatically from the other
`proteins (Figure 1D). At pH 4.5, silicone oil caused
`a steady increase in the turbidity over the 5 h,
`clearly reflecting aggregation. In contrast, the
`OD360 of the lysozyme/silicone oil mixtures at
`pH 6.5 and 7.2 decreased over extended periods
`(during 50–140 and 20–165 min, respectively).
`The pH 6.5 sample containing silicone oil ex-
`perienced a small increase in OD360, probably
`due to protein aggregation, prior to the decline.
`We attribute the decreasing OD to changes in the
`refractive index increment (dn/dc) of the protein
`particles as the protein undergoes further aggre-
`gation. Note that scattering intensity is pro-
`portional to the square of the refractive index
`increment. Thus, small decreases in the density
`of scattering particles relative to the monomeric
`protein itself can in principle lead to significant
`decreases in scattering.
`The results of this silicone oil-induced aggrega-
`tion study of several proteins reveal only limited
`information regarding general trends. The most
`obvious one is that the more hydrophobic proteins,
`BSA (classified as hydrophobic based on the well
`known presence of its apolar binding sites11) and
`
`JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 94, NO. 4, APRIL 2005
`
`ConA, had a greater tendency to aggregate than
`the relatively more hydrophilic ones (lysozyme
`and RNase A). This result was not unexpected
`and suggests that the interactions are at least
`in part apolar in nature. All proteins exhibited a
`pH-dependence in their tendency to aggregate in
`the presence of the oil. There was, however, no
`clear trend (e.g., a protein’s isoelectric point and
`the solution pH at which it experienced the largest
`(or smallest) change in optical density) to this de-
`pendence. For example, although BSA and ConA
`have similar isoelectric points (4.9 and 4.5–5.5,12
`respectively), ConA had the smallest silicone oil
`induced change in optical density at pH 7.2 while
`the pH 4.5 solution exhibited the least change for
`BSA. Although the increase in optical density was
`highest at pH 4.5 for both lysozyme and RNase A
`(two relatively small proteins with basic pIs),
`the kinetic profiles of the optical density data
`indicate that they are affected dissimilarly by the
`silicone oil.
`
`Effects of Silicone Oil on Secondary Structure
`and Thermal Stability
`
`Why do low concentrations of silicone oil cause
`proteins to aggregate? One possibility is that the
`oil structurally alters proteins resulting in aggre-
`gation competent states. To test this idea, we used
`CD to see if silicone oil induced changes in pro-
`tein secondary structure could be detected. Since
`absorption flattening is a potential problem in CD
`studies of proteins at high concentration and in
`turbid samples, it was necessary to lower the
`protein concentration to examine the effect of sili-
`cone oil on the secondary structure of the proteins.
`By using short pathlength cells and lower protein
`concentrations, undistorted CD spectra could be
`obtained in the presence of the oil. No unusual
`reduction in CD intensity or red shifts in peaks
`was observed, arguing that significant flatten-
`ing was not present. The far UV CD spectra of
`the four proteins at 208C in the presence and
`absence of silicone oil (0.5%) were indistinguish-
`able (data not shown). In most cases, the pre-
`sence of silicone oil (0.5%) also had no effect on
`the thermal unfolding temperature (Tm) of the
`proteins (Figure 2). BSA at pH 4.5 and 7.2 was
`the only protein for which silicone oil had even a
`modest statistically significant effect, with a 2–
`38C increase and decrease in Tm, respectively.
`This may at least partially reflect the existence
`of the well-known apolar binding sites on this
`protein.
`
`Novartis Exhibit 2253.005
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`SILICONE OIL INDUCED PROTEIN AGGREGATION
`
`923
`
`ConA
`
`BSA
`
`70
`
`75
`
`65
`
`u
`
`0
`--; 60
`I-
`
`70
`
`u
`
`0
`--; 65
`I-
`
`55
`
`50
`
`80
`
`pH 4.5
`
`pH 6.5
`
`pH 7.2
`
`lysozyme
`
`60
`
`55
`
`70
`
`pH 4.5
`
`pH 6.5
`
`pH 7.2
`
`RNase A
`
`75
`
`u
`'";70
`I-
`
`0
`
`65
`
`u
`
`0
`--; 60
`I-
`
`65
`
`60
`
`pH 4.5
`
`pH 6.5
`
`pH 7.2
`
`55
`
`50
`
`pH 4.5
`
`pH 6.5
`
`pH 7.2
`
`Figure 2. Effect of silicone oil on circular dichroism (CD) Tm. Black bars: Samples
`lacking silicone oil. White bars: Samples contain 0.5% silicone oil. The error bars
`represent the error of the Tm determined from the nonlinear curve fit of CD ellipticity data
`as a function of temperature.
`
`Effects of Silicone Oil on Protein
`Tertiary Structure
`
`The effect of silicone oil on the tertiary structure
`of the proteins as a function of temperature and
`pH was investigated by 2nd derivative analysis
`of the proteins’ UV absorbance peaks. The use of
`derivative analysis permits peak positions in the
`presence of residual scattering to still be accu-
`rately determined since such contributions are
`manifested as only gradual background slope
`increases.13 Errors in peak position are increased,
`however, due to variations in intensity due to
`temporal effects as scattering becomes more
`intense. Note that intrinsic fluorescence spectro-
`scopy cannot be used for related analyses since
`the presence of the oil produces large spectral
`shifts due to changes in solution polarity. In con-
`
`trast, oil induced shifts in absorption spectra are
`much less (although see below). Peak assign-
`ments are based on previously established de-
`terminations and are as follows: phenylalanine
`(245–270 nm), tyrosine (265–285 nm), trypto-
`phan (265–295 nm).8,14
`The representative data presented in Figure 3
`are those for the peaks in each protein that had
`the most significant change. Although the correla-
`tion is imperfect, monitoring tertiary structure
`changes provided a better indication that the pro-
`teins were more aggregation prone in the presence
`of silicone oil. In general, ConA and BSA (Tyr/Trp
`peak shown) peak positions differed only in post
`transition regions when silicone oil was present
`(Figures 3 and 4). Interpretation of the data in
`this region is complicated by the increased error
`due to aggregation at higher temperatures with
`
`JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 94, NO. 4, APRIL 2005
`
`Novartis Exhibit 2253.006
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`924
`
`JONES, KAUFMANN, AND MIDDAUGH
`
`ConApH6.5
`
`BSApH4.5
`
`-
`
`_ 268.4
`E
`:::
`:; 268.0
`
`Q,
`
`OJ)
`::: 267.6
`-9:!
`>
`e,: 267.2
`~
`
`266.8
`
`I ~
`
`,.
`
`lZ
`
`I I
`
`1
`
`ll'
`
`'I'
`
`'I'
`
`lj!
`
`\I
`
`'I'
`
`f
`
`-
`
`-280
`E
`:::
`,S 279
`oJ)
`:::
`.S:!
`~ 278
`~
`~
`
`277
`
`j
`~ i ! ! i i i i H
`
`!
`
`□
`
`□
`
`20
`
`40
`
`60
`
`80
`
`20
`
`40
`
`60
`
`80
`
`Temp. (0 C)
`
`Temp (0 C)
`
`RNase A pH 7.2
`
`lysozyme pH 7 .2
`
`-
`-
`-
`
`~ 253.8
`.:::
`OJ)
`:::
`-9:!
`Q,
`>
`e,:
`~
`
`253.4
`
`253.0
`20
`
`I I
`
`□
`
`0
`
`292.2
`
`: '. ! : ; 1 I 1 l ! I !
`
`8
`:::
`'-'
`.:::
`"S'Jl 291.8
`:::
`-9:!
`Q,
`>
`e,:
`~
`
`291.4
`
`~ ~ ~ ~ ~ ~
`Q 2 2 2
`! ! I I I •
`! ! ! !
`
`0
`
`2
`
`~ ~
`•
`I f I
`
`40
`
`60
`
`80
`
`20
`
`40
`
`60
`
`80
`
`Temp (0 C)
`
`Temp (0 C)
`
`Figure 3. Representative second derivative UV peak positions for each of the model
`proteins. Black symbols: No silicone oil; white symbols: samples contain 0.5% silicone oil.
`The error bars represent the SEM of two or three replicates.
`
`the silicone oil samples having larger error bars,
`presumably due to more intensive aggregation. As
`expected, peak positions are slightly shifted in the
`presence of the oil. In the lysozyme system, the
`sample containing silicone oil is red shifted with
`respect to the silicone oil-free sample. While this
`could, in principle, be indicative of a conforma-
`tional change that resulted in aromatic side chains
`moving to a less polar environment, it is much
`more likely that this simply reflects a decrease in
`polarity of the solvent due to the presence of the
`silicon oil. In contrast, the ca. 253 (Figure 3) and
`259 nm (data not shown) phenylalanine peaks of
`RNase A in the silicone oil-free buffers (pH 7.2 and
`
`6.5, respectively) were red shifted with respect to
`the samples containing silicone oil. This suggests
`that the environments of the phenylalanine resi-
`dues are shifted to a more polar environment in the
`presence of the silicone oil. Since the phenylala-
`nine residues in RNase A are deeply buried in the
`interior of the protein,15 this shift suggests that
`the structure has been slightly altered in the sili-
`cone oil sample, increasing the exposure of one or
`more of the phenylalanine residues to the solvent.
`Plots of peak position as function of temperature
`provide a measure of tertiary structure thermal
`stability. Slight differences in transition tempera-
`tures can be seen with certain peaks in the case of
`
`JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 94, NO. 4, APRIL 2005
`
`Novartis Exhibit 2253.007
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`SILICONE OIL INDUCED PROTEIN AGGREGATION
`
`925
`
`ConA (Figure 4). Melting curves for ConA (pH 4.5)
`display transitions between 60 and 658C. In con-
`trast, ConA at pH 6.5 and 7.2 both manifest
`transitions between 65 and 708C. These pH de-
`pendent effects are in agreement with the trend
`observed in Tm calculations. That is, ConA at pH
`4.5 has a lower transition temperature than ConA
`at pH 6.5 or 7.2. The transition temperatures for
`
`ConA at the various pH values were, however,
`essentially independent of the presence of silicone
`oil, which was also true for the Tm’s calculated from
`CD measurements. Furthermore, the transition
`temperatures of the peak position curves for all of
`the proteins investigated were essentially inde-
`pendent on the presence of (0.5%) silicone oil (e.g.,
`Figure 3).
`
`peak I pH 4.5
`
`peak 2 pH 4.5
`
`peak 3 pH 4.5
`
`• • • ■ • • ■ ~ t
`
`255
`
`]: 254
`°t. 253
`=
`..!l
`"
`;. 252
`~
`
`251
`
`f
`
`~
`
`I S 261
`
`262
`
`5
`'t,, 260
`=
`..!l
`~ 259
`"
`~ 258
`
`■ ■ ■ • ■ ~ ■ ~ ~
`
`I
`
`20
`
`40
`
`60
`
`80
`
`Temp. (°C)
`
`257
`20
`
`40
`
`60
`
`80
`
`Temp. ( 0 C)
`
`S 271
`5
`-=
`jf 269
`..!l
`"
`;,
`" 267
`~
`
`265
`20
`
`I 11
`
`~ ■ ■ ■ ■ ~ ■ i
`
`~
`
`■
`
`40
`
`60
`
`80
`
`Temp. (°C)
`
`peak 1 pH 6.5
`
`peak 2 pH 6.5
`
`peak 3 pH 6.5
`
`. .
`
`V
`
`.- V V
`
`i V V f l ! I
`
`...
`
`y
`
`"
`
`?
`
`•
`
`"
`
`"
`
`....
`
`i
`
`'
`
`~ i ;
`
`i I
`y
`
`"
`
`'t'
`
`"
`
`•
`
`I
`
`255
`s
`5 254
`t
`,i 253
`"
`;,
`"
`~ 252
`
`251
`20
`
`255
`
`]: 254
`
`t
`ii 253
`"il
`;,
`"
`~ 252
`
`251
`20
`
`262
`S 261
`s
`'t,, 260
`=
`..!l
`" 259
`;,
`"
`~
`258
`
`257
`20
`
`y
`
`40
`
`60
`
`80
`
`Temp.(°C)
`
`! I ! 269
`I OJ) =
`
`-s
`..
`..!l
`"
`"
`~ 267
`
`~
`
`•
`
`'
`
`....
`
`40
`
`60
`
`80
`
`20
`
`40
`
`60
`
`80
`
`Temp. ( 0 C)
`
`Temp. (°C)
`
`peak 1 pH 7.2
`
`peak 2 pH 7.2
`
`peak 3 pH 7.2
`
`!
`i ~ i i ~ • i · Q
`
`q2
`l ;i 260
`I
`
`261
`s
`=
`OJ)
`=
`..!l
`"
`;, 259
`"
`~
`
`~ i
`
`••
`
`i
`
`•
`
`•
`
`•
`
`i I ! PI
`
`269
`
`..... 11 l
`ii 267 . ~ .
`..
`
`]: 268
`-s
`
`"il
`;,
`"
`~ 266
`
`40
`
`60
`
`80
`
`Temp. (°C)
`
`258
`20
`
`40
`
`60
`
`80
`
`Temp. (°C)
`
`265
`20
`
`40
`
`60
`
`80
`
`Temp. ( 0 C)
`
`Figure 4. Second derivative UV peak position of concanavalin A (ConA) at pH 4.5, 6.5,
`7.2. Black symbols: no silicone oil; white symbols: samples contain 0.5% silicone oil. The
`error bars represent the SEM of three replicates. Aromatic amino acids represented by
`the various peaks are as follows: Phe (peaks 1 3); Tyr (peak 4); Tyr/Trp (peak 5); and Trp
`(peak 6).
`
`JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 94, NO. 4, APRIL 2005
`
`Novartis Exhibit 2253.008
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`926
`
`JONES, KAUFMANN, AND MIDDAUGH
`
`peak 4 pH 4.5
`
`' ' ' ' ' . . I I i I I
`
`40
`
`60
`
`80
`
`Temp. (° C)
`
`peak4 pH 6.5
`
`• i 1
`.
`
`•
`
`•
`
`y V V ~ I
`
`9
`
`9
`
`280
`
`e
`
`C
`:; 278
`'c,
`C
`a,
`ai
`> 276
`"' ;i:
`
`274
`20
`
`e 277
`-=-
`.c
`'c,
`C
`a,
`ai 275
`>
`"' ;i:
`
`286
`
`e
`
`C
`:; 285
`'c,
`C a,
`ai
`~ 284
`;i:
`
`283
`20
`
`285
`
`e
`-=-
`.c
`'c,
`C 284
`a,
`ai
`> "' ;i:
`
`peak 5 pH4.5
`
`peak 6 pH 4.5
`
`t ~
`• • ■ ■ 1 ■ ■ • ~ i ! I
`
`40
`
`60
`
`80
`
`Temp. (OC)
`
`e 293 .0
`-=-.c
`'c,
`C a,
`ai
`> "' ;i: 291.0
`
`29 2.0
`
`290.0
`20
`
`■ • ■ ■ ■ • ■ ~ i ' I !
`
`40
`
`60
`
`80
`
`Temp. (° C)
`
`peak6 pH 6.5
`
`peak5 pH 6.5
`
`• • • • • • • • • I I [ .
`
`9
`
`e 292
`.s
`.c
`'c,
`C
`a,
`ai 290
`> ;
`
`273+--- -~ - - -~ - - -~ - -
`20
`40
`60
`80
`
`2 8 3+ - - - -~ - - -~ - - -~ -
`20
`40
`60
`80
`
`288+ - - - -~ - - -~ - - -~ -
`40
`20
`60
`80
`
`.:
`
`Temp. (°C)
`
`Temp. (°C)
`
`peak4 pH 7.2
`
`" I
`! I ! I
`
`~ ij
`
`•
`
`i
`
`~ •
`
`; ~
`
`40
`
`60
`
`80
`
`Temp. (°C)
`
`e 277
`-=-.c
`'c,
`C
`a,
`ai 275
`
`> "' ;i:
`
`273
`20
`
`285.0
`
`e
`-=-.c 284.6
`'c,
`C a,
`ai
`> 284.2
`"' ;i:
`
`283.8
`20
`
`peak 5 pH 7.2
`
`~
`
`•
`
`•
`
`i
`
`i
`
`•
`
`•
`
`i
`
`I I "
`f I
`
`40
`
`60
`
`80
`
`Temp. (°C)
`
`Figure 4.
`
`(Continued)
`
`Temp. (°C)
`
`peak 6 pH 7.2
`
`293.0
`
`e 292.6
`-=-.c
`'c, 292.2
`C a,
`ai 291 .8
`> "' ;i:
`
`291.4
`
`291 .0
`20
`
`I 2 I ~
`!
`i
`
`!
`
`! .
`• •••
`
`i
`
`i
`
`•
`
`40
`
`60
`
`80
`
`Temp. (°C)
`
`In the discussion of the data from both the
`secondary and tertiary structure studies, no dis-
`tinction was made regarding the location of
`the protein responsible for the aggregation. The
`analytical techniques that we have employed are
`capable of reporting the biophysical properties
`of proteins in the bulk water phase, adsorbed at
`the oil/water interface, or partitioned into a bulk
`oil phase. Unfortunately, they do not distinguish
`between these environments. The data represent
`the average environment of the soluble protein.
`Thus, it is plausible that the aggregated pro-
`
`tein has undergone gross conformational changes
`that we have simply been unable to detect. Such a
`scenario would be possible for a small population of
`structurally altered, aggregation competent pro-
`tein. For example, if only 1% of the protein is
`adsorbed at the oil/water interface at any given
`time and the remaining soluble protein is structu-
`rally unaltered, relatively large perturbations in
`the structure of adsorbed protein may be experi-
`mentally reflected as only a minor change in the
`overall structure. This would be indistinguish-
`able from the situation in which a large population
`
`JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 94, NO. 4, APRIL 2005
`
`Novartis Exhibit 2253.009
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`of the protein (e.g., 99%) is adsorbed at the oil/
`water interface but has only a slightly altered
`structure. Since the purpose of this study was
`to determine whether common analytical tech-
`niques could detect biophysical changes leading to
`silicone oil induced protein aggregation and not
`necessarily to elucidate the specific location of the
`altered protein, the task of distinguishing between
`proteins in the various environments was not
`pursued.
`
`CONCLUSIONS
`
`In general, methods that are commonly used to
`monitor changes in protein structure do not pro-
`vide consistent evidence that silicone oil (0.5%)
`induces major structural changes that might be
`responsible for inducing aggregation. Most com-
`monly, protein aggregation is thought to arise
`from molten globule like states of proteins. Such
`states are usually detected by tertiary (but not
`secondary) structure alterations. That is clearly
`not the case here. Thus, it is possible that more
`subtle structural changes may be involved in
`the aggregation processes as hinted by some of
`the above observations. For example, changes
`in the dynamic states of the protein, i.e., shifts
`in the distribution of their native states may
`mediate aggregation. Most importantly, a direct
`effect of the oil on the interactions that mediate
`protein/protein interactions responsible for aggre-
`gation seems likely. Whatever the molecular
`basis for the observed aggregation behavior, how-
`ever, it can clearly be minimized by reducing the
`content of silicone oil in protein pharmaceutical
`formulations.
`
`ACKNOWLEDGMENTS
`
`We would like to thank Aaron Mohs for his con-
`tributions toward the dev

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket